Dr. Jasmine Cui is the Co-founder, Chairwoman & CEO of InnoCare Pharma (HKEX: 09969; SSE: 688428). InnoCare is a biopharmaceutical company rooted in China with the global vision to discover and develop novel treatment for cancer and autoimmune diseases. Dr. Cui has over 30 years of drug research & development experience.

Prior to founding InnoCare, Dr. Cui was the General Manager of BioDuro, responsible for BioDuro’s overall scientific and operational management, as well as business & resource management. Before BioDuro, Dr. Cui worked at Merck Research Laboratories for 14 years serving as the Chair of Early Development Team for development of drug candidates from preclinical to phase IIa.

Dr. Cui received her Ph.D. in molecular biology from Purdue University and completed her postdoctoral fellowship at Howard Hughes Medical Institute affiliated with the University of Michigan. Dr. Cui was the 17th SAPA President and the first female president for SAPA. She was included Fortune China Most Powerful Women in Business List for three times.